Residual transfusion risk for hepatitis B and C in southern Brazil, 1991-99
- 1 January 2001
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 8 (1), 78-82
- https://doi.org/10.1046/j.1365-2893.2001.00272.x
Abstract
A retrospective study of 139188 blood donor records for the period 1991-99 was conducted in the largest blood bank in the federal state of Santa Catarina, in southern Brazil. The incidence/window method, based on 11286 repeat donors with 8917 person-years of follow-up, was used to estimate the residual risk for transfusing hepatitis B and C due to infectious window periods for early, mid and late years of the decade. The residual risk for transfusing HBsAg contaminated blood decreased almost three times over the 1990 decade but still remains very high at 1 : 2077 (95% confidence limits 1 : 1075-1 : 4624), with a corresponding incidence of 3.00 (1.35-5.77) per 1000 person-years. Similarly, although residual risk for hepatitis C was reduced more than 30 times in late 1990s, compared with the earlier period, the risk of 1 : 13721 (1 : 7102-1 : 30820) and corresponding incidence of 0.51 (0.23-0.99) per 1000 person-years are still very high compared to developed countries. In addition to vaccination against hepatitis B and health promotion efforts aimed at reduction of hepatitis transmission, special measures such as PCR screening of pooled blood donations might be needed to rapidly achieve a further residual risk reduction in high prevalence areas.Keywords
This publication has 13 references indexed in Scilit:
- The use of polymerase chain reaction in plasma pools for the concomitant detection of hepatitis C virus and HIV type 1 RNATransfusion, 2003
- PCR for HVC, HCV and HIV-1 Experiences and First Results from a Rountine Screening Programme in a Large Blood Transfusion ServiceBiologicals, 1998
- Estimated Risk of Transmission of Hepatitis C Virus by Blood TransfusionVox Sanguinis, 1998
- Hepatitis C lookbackTransfusion Medicine Reviews, 1998
- The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infectionTransfusion Medicine Reviews, 1997
- A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor StudyTransfusion, 1997
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- A multicentre assessment of the specificity of ten anti-HBc screening testsTransfusion Medicine, 1995
- Prevalências do HBsAg, do anti-HBc e do anti-HCV na população de candidatos a doadores de sangue do Hemocentro-CampinasRevista do Instituto de Medicina Tropical de São Paulo, 1993
- Sensitivity of serological assays to identify blood donors with hepatitis C viraemiaThe Lancet, 1992